Dr. Alexander Edward Glick, MD

Dr. Glick practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in North Port, Florida.

Dr. Glick's NPI, 1598081911, was assigned on April 9, 2010. Dr. Glick graduated from Ross University School of Medicine in 2010. Dr. Glick holds Florida license ME128071.

Dr. Glick's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1390 Grand Venture Dr, North Port, FL 34286 in Sarasota County. The practice phone is (239) 541-4633.

Dr. Glick's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in North Port, Florida. Dr. Glick is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Glick to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Glick practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Glick's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Glick is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Glick's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Glick treats.

CMS data shows 275,929 Medicare services from Dr. Glick across 69 procedure codes in 2024, for 1,735 Medicare patients. Medicare paid $4,536,609 for them.

CMS counts 1,735 Medicare patients who saw Dr. Glick in 2024. The largest group is 75 to 84, with 773 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Glick's median patient age at 74, with 55% women.

In 2024, Dr. Glick wrote 2,381 Medicare Part D claims for 461 patients. 70% of them were for generic drugs. CMS names the drug for 2,062 of them, across 56 drugs with 11 or more claims each, at $8,134,275 in total drug cost. In 2023, CMS named 2,003 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Glick for performance year 2024, reported as part of a group. Dr. Glick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Glick as offering telehealth.

Dmand AI links 2 papers to Dr. Glick, published from 2015 to 2017. Dr. Glick's most frequent co-authors are Adam Raben, MD and Michael J. Stender, MD.

Dmand AI links Dr. Glick to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell and Leukemia, B-Cell. Open Payments lists research payments to Dr. Glick that name 2 trials.

CMS Open Payments shows 935 general payments to Dr. Glick from 74 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Janssen Pharmaceuticals, Inc paid the most, $5,010. It also lists 3 research payments totaling $8,240 from 2023 to 2024, naming 2 clinical trials.

Dr. Glick graduated from Ross University School of Medicine in 2010.

Dr. Glick is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.